Sanofi ADR (SNY) concluded trading on Thursday at a closing price of $50.74, with 4.7 million shares of worth about $238.31 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.06% during that period and on January 16, 2025 the price saw a gain of about 2.77%. Currently the company’s common shares owned by public are about 2.61B shares, out of which, 2.50B shares are available for trading.
Stock saw a price change of 3.07% in past 5 days and over the past one month there was a price change of 8.42%. Year-to-date (YTD), SNY shares are showing a performance of 5.20% which decreased to -1.59% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $45.22 but also hit the highest price of $58.97 during that period. The average intraday trading volume for Sanofi ADR shares is 2.30 million. The stock is currently trading 4.40% above its 20-day simple moving average (SMA20), while that difference is up 4.07% for SMA50 and it goes to -0.42% lower than SMA200.
Sanofi ADR (NASDAQ: SNY) currently have 2.61B outstanding shares and institutions hold larger chunk of about 11.31% of that.
The stock has a current market capitalization of $126.63B and its 3Y-monthly beta is at 0.54. PE ratio of stock for trailing 12 months is 27.97, while it has posted earnings per share of $1.81 in the same period. Its PEG reads 3.42 and has Quick Ratio of 0.65 while making debt-to-equity ratio of 0.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SNY, volatility over the week remained 1.51% while standing at 1.64% over the month.
Stock’s fiscal year EPS is expected to drop by -10.07% while it is estimated to increase by 11.77% in next year. EPS is likely to grow at an annualized rate of 8.18% for next 5-years, compared to annual growth of 2.68% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Argus on July 26, 2024 offering a Buy rating for the stock and assigned a target price range of between $55 and $60 to it. Coverage by Morgan Stanley stated Sanofi ADR (SNY) stock as an Equal-weight in their note to investors on January 23, 2024, suggesting a price target of $55 for the stock. Stock get a Hold rating from Stifel on October 30, 2023.
